City
Epaper

Covid cases in Karnataka at 628, 15 deaths reported

By IANS | Updated: February 25, 2022 23:10 IST

Bengaluru, Feb 25 Karnataka logged 628 new Covid cases against 1,349 discharges on Friday, while there were 15 ...

Open in App

Bengaluru, Feb 25 Karnataka logged 628 new Covid cases against 1,349 discharges on Friday, while there were 15 more deaths, against 1,692 discharges and 19 deaths on the previous day.

The number of total active Covid cases in the state stood at 7,518. The positivity rate stood at 0.92 per cent, recovery rate stood at 98.79 per cent, and case fatality rate for the day has been 2.38 per cent.

The number of new Covid cases in Bengaluru Urban came down to 346 against 769 discharges, while there were 12 deaths. The active cases in the city total 3,973.

Yadgir and Gadag districts in north Karnataka recorded zero cases.

A total of 615 patients are being treated in hospitals across the state.

In the last 24 hours, 67,583 Covid tests were conducted.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalNTK leader Seeman walks off stage amid chaos in TN‘s Villupuram protest meeting

NationalPolitics heats up in Odisha over alleged video of Puri victim circulating on social media

NationalBengal: Police claim 'violent movement' planned for Monday in the name of march to SSC office

Other SportsDPL: Sumit Beniwal’s five-for seals big win for South Delhi Superstarz against Purani Dilli 6

InternationalUAE conducts 73rd airdrop of aid over Gaza Strip

Health Realted Stories

HealthBangladesh: One more person dies of dengue, 2025 toll rises to 105

HealthPrevention, not just medication, key to tackling obesity and diabetes: Jitendra Singh

HealthAyush seminar to boost ayurveda‑based paediatric healthcare

HealthIIT Kharagpur launches healthcare and technology school to train youth as health professionals

HealthNovel live type 1, 3 oral polio vaccines show promise in phase 1 trial